The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Will The Market Size Of The Single-Molecule Real-Time Sequencing (SMRT) Market Evolve From 2026 To 2030?
The market for single-molecule real-time sequencing (smrt) has experienced robust expansion in recent times. This market is projected to expand from $3.36 billion in 2025 to $3.63 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 8.1%. Historically, this growth was driven by factors such as the proliferation of genomic research initiatives, the rising uptake of next-generation sequencing platforms, an escalating demand for whole genome sequencing, increased investments in life sciences research, and innovations in sequencing chemistry.
The single-molecule real-time sequencing (SMRT) market is anticipated to experience robust expansion over the next few years. It is projected to achieve a market size of $4.9 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.8%. The projected growth in this period stems from several factors, including the expanding use of precision medicine approaches, the escalating demand for population-scale genomics, the broadening of clinical genomics applications, the increasing integration of AI-driven bioinformatics, and augmented funding for advanced sequencing technologies. Significant trends identified for the forecast period include the increasing adoption of long-read sequencing technologies, the rising utilization of SMRT sequencing for detecting structural variants, the growing requirement for high-accuracy epigenetic analysis, the expansion of real-time sequencing workflows, and a sharpened focus on resolving complex genomes.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19696&type=smp
Which Growth Drivers Are Contributing To The Progress Of The Single-Molecule Real-Time Sequencing (SMRT) Market?
The increasing need for personalized medical approaches is projected to boost the expansion of the single-molecule real-time sequencing (SMRT) market in the coming period. Personalized medicine, also known as precision medicine, is a healthcare strategy that customizes treatments and care plans for patients by considering their unique genetic makeup, environmental influences, and lifestyle choices. This growing demand stems from progress in genomic technologies, allowing for more accurate and customized therapies, alongside a heightened focus on individual patient care to achieve improved results. SMRT technology significantly improves precision medicine by delivering precise and comprehensive genomic and epigenetic data, which aids in better diagnoses, tailored treatments, and superior patient outcomes. For example, in May 2025, as reported by the U.S.-based professional organization, the Personalized Medicine Coalition (PMC), the U.S. Food and Drug Administration (FDA) sanctioned 18 new personalized medicines in 2023, constituting approximately 38% of all recently approved therapeutic molecular entities. Consequently, the heightened requirement for precision medicine is a key factor driving growth in the single-molecule real-time sequencing (SMRT) market. The increasing occurrence of genetic conditions is anticipated to fuel the expansion of the single-molecule real-time sequencing (SMRT) market in the coming period. Genetic disorders are medical conditions resulting from irregularities in a person’s DNA, either inherited or arising from mutations, impacting physical development, metabolic processes, or general well-being. The escalating frequency of genetic disorders is predominantly driven by greater public awareness, improvements in diagnostic techniques, and contributing factors like environmental impacts and the age of parents. In the context of genetic disorders, SMRT technology offers precise, long-read DNA sequences, facilitating the identification of intricate mutations and structural variations that might be overlooked by conventional methods. As an illustration, in March 2024, the Gene People, a registered charity in the UK supporting individuals with genetic disorders, reported the existence of over 6,000 genetic conditions, with new ones being identified daily. Within the UK, 1 in 25 children is impacted, leading to 30,000 new diagnoses each year, and more than 2.4 million individuals are currently living with genetic conditions. Consequently, the growing prevalence of genetic disorders is a significant catalyst for growth in the single-molecule real-time sequencing (SMRT) market.
Which Segment Areas Are Covered In The Single-Molecule Real-Time Sequencing (SMRT) Market Analysis?
The single-molecule real-time sequencing (smrt) market covered in this report is segmented –
1) By Product: Consumable, Instrument, Services
2) By Application: DNA Sequencing, RNA Sequencing, Epigenetics, Whole Genome Sequencing, Other Applications
3) By End-Users: Hospitals, Diagnostic Laboratories, Biopharmaceutical Companies, Academic Institutes And Research Centers, Other End-Users
Subsegments:
1) By Consumable: Reagents, Sample Preparation Kits, Flow Cells
2) By Instrument: SMRT Sequencers, Accessories, Software
3) By Services: Data Analysis Services, Sequencing Services, Technical Support Services
Which Global Companies Are Actively Competing In The Single-Molecule Real-Time Sequencing (SMRT) Market?
Major companies operating in the single-molecule real-time sequencing (smrt) market are Thermo Fisher Scientific Inc., Illumina Inc., Qiagen N.V., BGI Group, 10x Genomics Inc., Ginkgo Bioworks Inc., Oxford Nanopore Technologies Limited, Genewiz Inc., Pacific Biosciences of California Inc., Macrogen Inc., Element Biosciences Inc., Asuragen Inc., BioNano Genomics Inc., Zymo Research Corporation, Dovetail Genomics LLC, SeqWell Inc., Paragon Genomics Inc., Nabsys Inc., Eurofins Scientific SE, Novogene Corporation
Read the full single-molecule real-time sequencing (smrt) market report here:
What Are The Leading Geographic Regions In The Single-Molecule Real-Time Sequencing (SMRT) Market?
North America was the largest region in the single-molecule real-time sequencing (SMRT) market in 2025. The regions covered in the single-molecule real-time sequencing (smrt) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Single-Molecule Real-Time Sequencing (SMRT) Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=19696&type=smp
Browse Through More Reports Similar to the Global Single-Molecule Real-Time Sequencing (SMRT) Market 2026, By The Business Research Company
Molecular Biology Enzymes And Kits And Reagents Global Market Report
Neuroscience Global Market Report
https://www.thebusinessresearchcompany.com/report/neuroscience-global-market-report
Typhoid Vi Polysaccharide Vaccine Global Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model